Abnormal endothelium-dependent coronary vasomotion in hypertensive patients

Evans Memorial Department of Clinical Research, Boston University Medical Center, Massachusetts.

Coronary vasomotion is abnormal in hypertensive patients, as evidenced by reduced coronary vasodilator reserve, but endothelium-dependent coronary vasomotion in hypertensive patients has not been studied. To assess the integrity of endothelium-dependent vasodilation, the response of coronary arteries to acetylcholine (an endothelium-dependent vasodilator) and nitroglycerin (an endothelium-independent vasodilator) was studied in 14 patients undergoing cardiac catheterization. Eight patients with essential hypertension were compared with six normotensive patients. None had obstructive disease detectable by coronary arteriography. Coronary artery diameter was measured with digital-subtracted arteriography and coronary blood flow velocity with a Doppler flow velocity catheter. At baseline, coronary artery diameter was similar in the hypertensive and the normotensive control patients (2.4 +/- 0.3 vs. 2.8 +/- 0.7 mm). During intracoronary acetylcholine infusion (30 micrograms/min), coronary artery diameter decreased to 1.3 +/- 0.7 mm in the hypertensive patients (p less than 0.005), but was unchanged (2.7 +/- 0.8 mm) in the normotensive patients. With intracoronary nitroglycerin (200 micrograms), coronary artery diameter increased significantly in both groups. Calculated coronary blood flow decreased during acetylcholine infusion by 59 +/- 31% in the hypertensive patients but increased by 3 +/- 3% in the normotensive group (p less than 0.005). There was a significant negative correlation between the percent change in estimated coronary blood flow during acetylcholine infusion and mean arterial pressure measured at baseline (r = 0.67, p less than 0.02). Therefore, these hypertensive patients exhibited marked coronary vasoconstriction in response to intracoronary acetylcholine but normal vasodilation in response to nitroglycerin, suggesting abnormal endothelium-dependent vasodilation.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. Kosch, A. Levers, D. Lang, V. Bartels, K. H. Rahn, H. Pavenstadt, and M. Hausberg A randomized, double-blind study of valsartan versus metoprolol on arterial distensibility and endothelial function in essential hypertension Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2280 - 2285. [Abstract] [Full Text] [PDF]

				A. Barac, U. Campia, and J. A. Panza Methods for Evaluating Endothelial Function in Humans Hypertension, April 1, 2007; 49(4): 748 - 760. [Full Text] [PDF]

				D. J Green, A. Maiorana, G. O'Driscoll, and R. Taylor Effect of exercise training on endothelium-derived nitric oxide function in humans J. Physiol., November 15, 2004; 561(1): 1 - 25. [Abstract] [Full Text] [PDF]

				N. Gokce L-Arginine and Hypertension J. Nutr., October 1, 2004; 134(10): 2807S - 2811S. [Abstract] [Full Text] [PDF]

				L. Cominacini, A. Fratta Pasini, U. Garbin, C. Nava, A. Davoli, M. Criscuoli, A. Crea, T. Sawamura, and V. Lo Cascio Nebivolol and its 4-keto derivative increase nitric oxide in endothelial cells by reducing its oxidative inactivation J. Am. Coll. Cardiol., November 19, 2003; 42(10): 1838 - 1844. [Abstract] [Full Text] [PDF]

				J. Sundell and J. Knuuti Insulin and myocardial blood flow Cardiovasc Res, February 1, 2003; 57(2): 312 - 319. [Abstract] [Full Text] [PDF]

				K. J. Stewart Exercise Training and the Cardiovascular Consequences of Type 2 Diabetes and Hypertension: Plausible Mechanisms for Improving Cardiovascular Health JAMA, October 2, 2002; 288(13): 1622 - 1631. [Abstract] [Full Text] [PDF]

				R. M. Kisabeth Laboratory Adaptations--Changing Expectations Clin. Chem., August 1, 2001; 47(8): 1509 - 1515. [Full Text] [PDF]

				N. Tzemos, P. O. Lim, and T. M. MacDonald Nebivolol Reverses Endothelial Dysfunction in Essential Hypertension: A Randomized, Double-Blind, Crossover Study Circulation, July 31, 2001; 104(5): 511 - 514. [Abstract] [Full Text] [PDF]

				H. Suzuki, H. Ikezaki, D. Hong, and I. Rubinstein PGH2-TxA2-receptor blockade restores vasoreactivity in a new rodent model of genetic hypertension J Appl Physiol, June 1, 2000; 88(6): 1983 - 1988. [Abstract] [Full Text] [PDF]

				S. Hamasaki, J. Al Suwaidi, S. T. Higano, K. Miyauchi, D. R. Holmes Jr., and A. Lerman Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1654 - 1660. [Abstract] [Full Text] [PDF]

				H. Laine, P. Nuutila, M. Luotolahti, C. Meyer, T. Elomaa, P. Koskinen, T. Ronnemaa, and J. Knuuti Insulin-Induced Increment of Coronary Flow Reserve Is Not Abolished by Dexamethasone in Healthy Young Men J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1868 - 1873. [Abstract] [Full Text]

				J. F. Beltrame, S. Sasayama, and A. Maseri Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and caucasian patients J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1442 - 1452. [Abstract] [Full Text] [PDF]

				J. Frielingsdorf, P. Kaufmann, T. Suter, R. Hug, and O. M. Hess Percutaneous Transluminal Coronary Angioplasty Reverses Vasoconstriction of Stenotic Coronary Arteries in Hypertensive Patients Circulation, September 22, 1998; 98(12): 1192 - 1197. [Abstract] [Full Text] [PDF]

				H. Laine, O. T. Raitakari, H. Niinikoski, O.-P. Pitkanen, H. Iida, J. Viikari, P. Nuutila, and J. Knuuti Early impairment of coronary flow reserve in young men with borderline hypertension J. Am. Coll. Cardiol., July 1, 1998; 32(1): 147 - 153. [Abstract] [Full Text] [PDF]

				H. C. McGill Jr, C. A. McMahan, R. E. Tracy, M. C. Oalmann, J. F. Cornhill, E. E. Herderick, and J. P. Strong Relation of a Postmortem Renal Index of Hypertension to Atherosclerosis and Coronary Artery Size in Young Men and Women Arterioscler Thromb Vasc Biol, July 1, 1998; 18(7): 1108 - 1118. [Abstract] [Full Text] [PDF]

				F. J. Miller Jr., K. C. Dellsperger, and D. D. Gutterman Pharmacologic activation of the human coronary microcirculation in vitro: endothelium-dependent dilation and differential responses to acetylcholine Cardiovasc Res, June 1, 1998; 38(3): 744 - 750. [Abstract] [Full Text] [PDF]

				C. Cardillo and J. A Panza Impaired endothelial regulation of vascular tone in patients with systemic arterial hypertension Vascular Medicine, May 1, 1998; 3(2): 138 - 144. [Abstract] [PDF]

				A. Nitenberg, F. Paycha, S. Ledoux, R. Sachs, J.-R. Attali, and P. Valensi Coronary Artery Responses to Physiological Stimuli Are Improved by Deferoxamine but not by L-Arginine in Non Insulin-Dependent Diabetic Patients With Angiographically Normal Coronary Arteries and No Other Risk Factors Circulation, March 3, 1998; 97(8): 736 - 743. [Abstract] [Full Text] [PDF]

				J. L. Houghton, V. E. Smith, D. S. Strogatz, N. L. Henches, W. M. Breisblatt, and A. A. Carr Effect of African-American Race and Hypertensive Left Ventricular Hypertrophy on Coronary Vascular Reactivity and Endothelial Function Hypertension, March 1, 1997; 29(3): 706 - 714. [Abstract] [Full Text]

				H. Hayakawa and L. Raij The Link Among Nitric Oxide Synthase Activity, Endothelial Function, and Aortic and Ventricular Hypertrophy in Hypertension Hypertension, January 1, 1997; 29(1): 235 - 241. [Abstract] [Full Text] [PDF]

				Y. Higashi, T. Oshima, N. Sasaki, N. Ishioka, Y. Nakano, R. Ozono, M. Yoshimura, K. Ishibashi, H. Matsuura, and G. Kajiyama Relationship Between Insulin Resistance and Endothelium-Dependent Vascular Relaxation in Patients With Essential Hypertension Hypertension, January 1, 1997; 29(1): 280 - 285. [Abstract] [Full Text] [PDF]

				I. Antony, G. Lerebours, and A. Nitenberg Angiotensin-Converting Enzyme Inhibition Restores Flow-Dependent and Cold Pressor Test Induced Dilations in Coronary Arteries of Hypertensive Patients Circulation, December 15, 1996; 94(12): 3115 - 3122. [Abstract] [Full Text]

				J. Frielingsdorf, C. Seiler, P. Kaufmann, G. Vassalli, T. Suter, and O. M. Hess Normalization of Abnormal Coronary Vasomotion by Calcium Antagonists in Patients With Hypertension Circulation, April 1, 1996; 93(7): 1380 - 1387. [Abstract] [Full Text]

				E. D. Frohlich, D. Aristizabal, F. Soria, and F. H. Messerli Investigative Concerns in Demonstrating Reduced Risk from Reversing Left Ventricular Hypertrophy Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1996; 1(1): 17 - 22. [Abstract] [PDF]

				I. Antony, G. Lerebours, and A. Nitenberg Loss of Flow-Dependent Coronary Artery Dilatation in Patients With Hypertension Circulation, March 15, 1995; 91(6): 1624 - 1628. [Abstract] [Full Text]

				J. A. Panza, C. E. Garcia, C. M. Kilcoyne, A. A. Quyyumi, and R. O. Cannon III Impaired Endothelium-Dependent Vasodilation in Patients With Essential Hypertension : Evidence That Nitric Oxide Abnormality Is Not Localized to a Single Signal Transduction Pathway Circulation, March 15, 1995; 91(6): 1732 - 1738. [Abstract] [Full Text]

				W. Motz, S. Scheler, B. Schwartzkopff, and B. E. Strauer Evaluation of Cardiac Damage in Hypertension European Journal of Cardiovascular Prevention & Rehabilitation, February 1, 1995; 2(1): 16 - 26. [Abstract] [PDF]

				K. Egashira, S. Suzuki, Y. Hirooka, H. Kai, M. Sugimachi, T. Imaizumi, and A. Takeshita Impaired Endothelium-Dependent Vasodilation of Large Epicardial and Resistance Coronary Arteries in Patients With Essential Hypertension : Different Responses to Acetylcholine and Substance P Hypertension, February 1, 1995; 25(2): 201 - 206. [Abstract] [Full Text]